LeMaitre Vascular, Inc. (LMAT) Q3 2010 Earnings Results

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 1.15%

Lemaitre Vascular's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 1.15%. This could suggest that investors were looking for more comprehensive revenue details or future guidance, which were not provided.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.09	N/A	+12.50%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about the company's direction. They emphasized the need for continued focus on operational improvements.

Management highlighted the importance of maintaining operational efficiency.

They noted ongoing investments in product development to drive future growth.

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 1.15%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 1.15%

Key numbers

Management commentary